Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
2000
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Why Don't Physicians Follow Clinical Practice Guidelines?
1999 Standout
The Infectivity ofCryptosporidium parvumin Healthy Volunteers
1995 Standout
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
2010
Cystic Fibrosis Pulmonary Guidelines
2009
Laboratory parameter profiles among patients with cystic fibrosis
2006
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Pathogenetic Mechanisms of Septic Shock
1993 Standout
A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis
1990
Respiratory Infections With Pseudomonas aeruginosa in Children With Cystic Fibrosis
2002
A Preliminary Study of Aerosolized Recombinant Human Deoxyribonuclease I in the Treatment of Cystic Fibrosis
1992
Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: A case report and review of the pediatric literature
1997
Lack of Unique Ciprofloxacin Pharmacokinetic Characteristics in Patients with Cystic Fibrosis
1988
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Defining a pulmonary exacerbation in cystic fibrosis
2001
An Outbreak of Tuberculosis with Accelerated Progression among Persons Infected with the Human Immunodeficiency Virus
1992 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Pediatric critical care physicians' attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia
1995
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Progressive epitope-blocked panning of a phage library for isolation of human RSV antibodies
2002
Cystic Fibrosis Pulmonary Guidelines
2007
Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients
1992
Defining an exacerbation of pulmonary disease in cystic fibrosis*
2001
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Persistent Infection with Small Colony Variant Strains of Staphylococcus aureus in Patients with Cystic Fibrosis
1998
Severe Sepsis and Septic Shock
2013 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
Efficacy of once‐daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: A preliminary study*
2001
Antiviral chemotherapeutic agents against respiratory viruses
2004
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
2010 StandoutNature
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Outbreaks of Infections with Erythromycin-resistant Group A Streptococci in Child Day Care Centres
1990
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Resistance to Erythromycin in Group A Streptococci
1992
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
2001 StandoutNature
Tuberculosis Testing
1996
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
1995
Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
1991
Evaluation of New Anti-Infective Drugs for the Treatment of Acute Infectious Diarrhea
1992
Necrotizing Enterocolitis
2011 Standout
Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa
1994
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Cystic fibrosis: A review of pulmonary infections and interventions
1987
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Cystic Fibrosis Pulmonary Guidelines
2013
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Intracranial complications of mucormycosis: An experimental model and clinical review
1992
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Airway Mucus Function and Dysfunction
2010 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
2008
Reduction of Sputum Pseudomonas aeruginosa Density by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone
1990
Transfusion transmitted Yersinia enterocolitica infection in New Zealand
1997
Immunologic Aspects of Cystic Fibrosis
1988
Recent Advances in Varicella-Zoster Virus Infection
1999
Successful Treatment of Sinusitis Caused by Cunninghamella bertholletiae
1994
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
1991
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
World-wide development of antibiotic resistance in pneumococci
1987
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Evaluation of Universal Hepatitis B Immunization Practices of Illinois Pediatricians
1994
Herpes Zoster
2002 Standout
Faecal candida and diarrhoea
2001
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
1993 StandoutNatureNobel
Cystic fibrosis
2009
Antibiotic Pharmacokinetics in Cystic Fibrosis
1987
Extensive Transmission ofMycobacterium tuberculosisfrom a Child
1999
Antibiotic-Associated Diarrhea
2002 Standout
The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis
1995
Outcome measures for clinical trials in cystic fibrosis Summary of a Cystic Fibrosis Foundation Consensus Conference
1994
Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction
2001
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Multiresistant Strains of Pseudomonas aeruginosa
2000
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Burkholderia cepacia
2000
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Rheology of Cystic Fibrosis Sputum after in vitro Treatment with Hypertonic Saline Alone and in Combination with Recombinant Human Deoxyribonuclease I
1997
Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis
2003
Inhaled antibiotics in cystic fibrosis: Is there a therapeutic effect?
1986
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
1995
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
1984
Clinical Prediction Rules
1985 Standout
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
Antibiotic-Resistant Streptococcus pneumoniae: Clinical and Epidemiologic Aspects
1981
Vitamin A Supplementation and Child Mortality
1993
Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease
1979 Standout
Zygomycetes in Human Disease
2000 Standout
Oxygen-Dependent Microbial Killing by Phagocytes
1978 Standout
Campylobacter Enteritis
1981
Practice Guidelines for the Management of Infectious Diarrhea
2001
Failure of Monoclonal Antibodies to Core Glycolipid to Bind Intact Smooth Strains of Escherichia coli
1985
Torulopsis glabrata infections in patients with cancer
1976
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia
1989
Varicella-zoster virus
1996 Standout
Use of mucin and hemoglobin in experimental murine Gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region
1986
Characterization of murine monoclonal antibodies to Escherichia coli J5
1986
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1991
Analysis of the fine specificity and cross-reactivity of monoclonal anti-lipid A antibodies.
1986
FREQUENT ANTIBIOTIC THERAPY IMPROVES SURVIVAL OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTION
1983
THE PATHOGENESIS OF AMYOTROPHIC LATERAL SCLEROSIS
1972
Antibiotic activity in sputum
1986
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
1990
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission
2003
Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria
1984
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
1993
Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin
1987
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Measuring the Accuracy of Diagnostic Systems
1988 StandoutScience
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests
1978 Standout
Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis
1987
Severity of Respiratory Syncytial Virus Bronchiolitis Is Affected by Cigarette Smoke Exposure and Atopy
2005
Cross-Reactive Immunoprotective Antibodies to Escherichia coli 0111 Rough Mutant J5
1985
RE-EVALUATION OF NITROBLUE- TETRAZOLIUM TEST
1973
Antibiotic therapy in cystic fibrosis: Evaluation of clinical trials
1986
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
1983
The Crisis in Antibiotic Resistance
1992 StandoutScience
Necrotizing Enterocolitis: Treatment Based on Staging Criteria
1986 Standout
Single and Combination Antibiotic Susceptibilities of Planktonic, Adherent, and Biofilm-Grown Pseudomonas aeruginosa Isolates Cultured from Sputa of Adults with Cystic Fibrosis
2002
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States
1990
Systemic Antifungal Agents
1998
Antibacterial Therapy in Cystic Fibrosis
1988
INFECTIONS OF THE HEAD AND NECK IN DIABETES MELLITUS
1995
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
1983
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli
1982
The Biology and Detection of Immune Complexes
1980
Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis
1984
Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.
1993
Torulopsis Glabrata Urinary Infections: A Review
1988
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
1984 Standout
Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis
1987
Reduction in Viscosity of Cystic Fibrosis Sputum in Vitro by Gelsolin
1994 Science
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time
1987
NITROBLUE-TETRAZOLIUM TESTS
1974
Comparison of Agar Diffusion Methodologies for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
2000
Works of Melvin I. Marks being referenced
Screening for tuberculosis in infants and children
1994
Universal hepatitis B immunization
1992
Update on tuberculosis skin testing of children
1996
Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections
1996
The use of oral acyclovir in otherwise healthy children with varicella
1993
Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
1999
Antibiotic Therapy for Bronchopulmonary Infections in Cystic Fibrosis
2015
Clinical significance of Staphylococcus aureus in cystic fibrosis
1990
Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis
1988
Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial
2002
In vitro Activity of Moxalactam and Cefoperazone against <i>Streptococcus pneumonia</i><i>e</i> with Differing Susceptibilities to Penicillin
1982
A controlled trial comparing sulfamethoxazole-trimethoprim, ampicillin, and no therapy in the treatment of salmonella gastroenteritis in children
1973
Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia enterocolitica gastroenteritis
1984
Yeast colonization in hospitalized and nonhospitalized children
1975
The Exposure of Health Care Workers to Ribavirin Aerosol
1989
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin
1981
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum
1990
The glomerulopathy of congenital syphilis—an immune deposit disease
1972
Carbenicillin and gentamicin: Pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections
1971
Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection
1993
Vitamin A levels in children with measles in Long Beach, California
1992
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution
1980
Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and prevention
1992
Campylobacter gastroenteritis in children
1979
Interaction of Ketoconazole with Rifampin and Isoniazid
1984
In vitro Activity of Ciprofloxacin against Pediatric Pathogens
1985
Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic
1987
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
1982
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
1980
Is Clostridium difficile pathogenic in infants?
1982
Yersinia enterocolitica gastroenteritis: A prospective study of clinical, bacteriologic, and epidemiologic features
1980
Torulopsis glabrata— An Opportunistic Pathogen in Man
1970
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis
1981
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin
1982
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis
1981
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
1982
Synergistic action of amphotericin B and rifampin against Rhizopus species
1987
THE HISTOCHEMICAL NITROBLUE TETRAZOLIUM REDUCTION TEST IN THE DIFFERENTIAL DIAGNOSIS OF ACUTE INFECTIONS
1971